Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

B5W2 > Bone Metabolism > Flashcards

Bone Metabolism Flashcards

1
Q

What makes up the skeleton?

A
  • Skeleton is 40% organic - predominantly type 1 collagen, but also non-collagenous proteins are present.
  • 60% of it is inorganic (calcium hydroxyapatite)
  • Trabecular bone has a wide surface area, structure which is mechanically strong.
  • Trabecular bone is actually a target area for bone remodelling.
  • Those bite marks you see are resorption pits.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What would you find it you were to look close up at the resorption pits?

A
  • You’d see osteoclasts and osteoblasts.

- You can see the osteoclast sitting in the resorption pit, removing away the bone.

  • Osteoblasts are mononuclear single nucleotide cells (cuboidal cells) which produce type-1 collagen and new bone matrix (unmineralised)
  • Some osteoblasts bury themselves alive (in the red bit) in the bone matrix, and become osteocytes in the bone matrix.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Give an overview of bone remodelling.

A
  1. Resorption - osteoclasts arrive at the bone surface and start to resorb the stuff.
  2. Then reversal phase, switch from absorption to formation (osteoblasts lay down initially un-mineralised type-1 collagen) and later on that becomes mineralised to bone.
  3. Then finally, calcium ion released into system.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What signalling mechanisms are involved in controlling cells that can affect calcium levels in circulation?

What is bone matabolism?

A
  • Bone metaboism drives bone remodelling.
  • Maintains levels of ionised calcium in blood within a defined range.
  • Signalling mechanisms include:

- Parathryoid Hormone (PTH)

- 1,25 (OH)2 vitamin D3

  • Calcitonin

- Growth Hormone

- Growth Factors (FGFs, TGFs)

- Oestrogen

- Cytokines (e.g. Interleukin-1, interferon-y)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What should serum concentration of calcium be at?

A
  • Reccomended daily intake - 1000mg
  • 99% of calcium in skeleton
  • 1% in extracellular fluid and soft tissues

Serum Concentration of calcium = 2.25-2.6mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the three forms of calcium found in serum?

A
  • Ionised calcium (Ca2+) (about 50% of all calcium).
  • Protein-bound calcium (primarily to albumin - 40%)
  • Complexed calcium (mostly to citrate and phosphate, 10%)

It is the ionised calcium that is physiologically important.

Ca2+ ion levels are maintained by PTH, vitamin D, calcitonin (+ others)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the three definable fractions of inorganic phosphate int he serum:

A
  • Ionised phosphate (55%)
  • Protein-bound phosphate (10%)
  • Complexed phosphate (mostly to sodium, calcium and magnesium).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What regulates phosphate levels?

A
  • Parathyroid Hormone (PTH)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the usual levels of phosphate?

A
  • Major ionic species of phosphate in serum at pH 7.4 is the divalent anion (HP042-)

In contrast to rigid regulation of calcium levels, phosphate concentrations in serum vary quite widely, influenced by age, diet, pH, hormones.

Usually around 0.9-1.3 mmol/L.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How much phosphorus is found in the adult human body?

A
  • Approximately 600g
  • 85% in the skeleton
  • 15% in extracellular fluids, largely in the form of inorganic phosphate ions.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is vitamin D synthesised?

A

Vitamin D is synthesised from cholecalciferol.

Synthesised in skin from 7-dehydrocholesterol.

25-hydoxylation in the liver produces 25(OH)D3 - the main circulating metabolite with little biological activity.

1-hydroxylation in the kidney produces 1,25 (OH)2 vitamin D3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the principal hormonal form of Vitamin D?

A

1,25 (OH)2 Vitamin D3

This is the principal hormonal form of Vitamin D and is responsible for most of its biological actions.

1,25(OH)2 vitamin D3 production is tightly regulated and stimulated by PTH and inhibited by elevated serum Calcium and Phosphate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What actions does 1,25(OH)2 Vitamin D3 engage in?

A
  • It increases calcium and phosphate absorption from the intestine.
  • It mobilises calcium and phosphate from bone.
  • It induces marrow monocytes to differentiate into osteoclasts to stimulate born resorption.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the vitamin D3 metabolites?

A
  • 24-hydroxylation of 25(OH)D3 and 1,25(OH)2D3 produces 24,25(OH)2D3 and 1,24,25 (OH)3D3
  • 24-hydroxylation generally first stage in catabolism of active vitamin D metabolites.
  • 24-hydroxylase is induced by 1,25(OH)2D3 which produces a feedback mechanism to prevent vitamin D toxicity.
  • 24,25(OH)2D3 and 1,24,25 (OH)3D3 biological activities unclear.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Parathyroid Hormone? (PTH)

A
  • It is an 84 amino acid polypeptide.
  • Molecular weight 9,500
  • Half-life: 20 minutes.

‘It is secreted by the parathyroid gland in response to low plasma Ca2+ levels.’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the actions of PTH?

A
  • Stimulate osteoclastic bone resorption, therefore mobilises calcium from bone.
  • Intermittent low levels of PTH appear to stimulate osteoblastic bone formation.

- PTH mediates its effects predominantly through osteoblasts, which communicate directly with osteoclasts to transmit PTH-dependent effects on resorption.

  • Decreases renal calcium excretion

- Increases renal production of 1,25(OH)2 Vitamin D3.

- Increases blood calcium levels.

17
Q

What is parathyroid hormone-related protein (PTHrP)?

A
  • It is the product of normal and malignant cells.
  • It is required for normal development, regulator of proliferation and mineralisation of chondrocytes.
  • Acts predominantly locally and not systemically in physiological situations.
  • PTHrP is a major mediator of hypercalcaemia of malignancy.
  • PTHrP secreted by many types of malignant tumours (particularly breast and lung cancers) and promotes hyerpcalcaemia by activating the PTH/PTHrP receptor.
  • When secreted in excess (by malignancy), PTHrP can act systemically.
18
Q

Explain the role of Calcitonin

A
  • Calcitonin is a 32 amino acid polypeptide.
  • It is released from the parafollicular (C) cells of the thyroid in response to high plasma calcium levels (>2.25mmol/L).
  • Reduces bone resorption by activating calcitonin receptors expressed by osteobclasts.
19
Q

Explain the process of calcium metabolism.

A
  • Decreased in Ca2_ induces PTH secretion, which mobilises calcium (bones), decreases renal calcium excretion and increases renal synthesis of 1,25(OH)2D3 that also enhances calcium mobilisation and absorption (bones, intesine).
  • Increased Ca2+ increases calcitonin secretion (inhibits bone resorption) and decreases 1,25(OH)2D3 synthesis.
20
Q

How do Oestrogens affect bone turnover?

A

Oestrogens:

  • Important role in maintaining bone mass.
  • Reduce bone resorption by inhibiting osteoclastogenesis and inhibiting osteoclast function.
  • Oestrogen receptors expressed by both osteoblasts and osteoclasts.
  • High oestrogen doses can have anabolic effects.
21
Q

Explain how androgens affect bone turnover

A
  • Decreased andogen levels linked to lower bone density in men.
  • Correlation between hypogonadism in elderly men and incidence of hip and spinal osteoperosis.
  • Androgen supplementation can increase bone density in men and women.

- Androgens decrease bone resorption by directly targeting osteoclasts.

22
Q

What are the causes of Hypercalcaemia?

A
  • Primary hyperparathyroidism

- Malignancy (osteoclytic bone metastases)

  • Hyperthyroidism
  • Immobilisation
  • Vitamin D toxicity
23
Q

Explain Primary hyperparathyroidism

A

Symptoms:

  • At skeletal sites, excess PTH can lead to osteitis fibrosa cystica (replacement of bone with fibrous tissue)
  • Periosteal erosions, bone pain, fracture, deformity.
  • Skull and phalanges most affected
  • Kidney stones.
24
Q

Explain the causes of Hypocalcaemia

A
  • Renal Failure
  • Vitamin D deficiency
  • Prematurity - Immature Vitamin D Metabolism, Immature Parathyroid Gland.
25
Q

Explain the causes of secondary hyperparathyroidism

A
  • Physiological response to hypocalcaemia
  • Symptoms similar to primary hyperparathyroidism
26
Q

What can cause Osteomalacia and Rickets?

A
  • Vitamin D deficiency
  • Anticonvulsants that inhibit synthesis of 1,25(OH)2 vitamin D3

Inherited:

  • Vitamin D-dependent rickets (VDDR) type I (1-hydroxylase deficiency)
  • Vitamin D-dependent rickets (VDDR) type 2 (resistance to 1,25 (OH)2 vitamin D3
27
Q

What are the clinical features of Osteomalacia and Rickets?

A
  • Diffuse bone pain
  • Localised bone pain around hips
  • Muscle weakness.
  • Elevated alkaline phosphatase levels.
  • Decreased mineralisation.
  • Weight bearing long bones display a bowing demormity
28
Q

What are the epidemiological facts about Osteoporosis

A

Features:

1 in 2 women and 1 in 5 men over 50 will get osteoporosis.

  • Treatment costs 1.7 billion a year in the UK.
  • Caused by net loss of bone mass, uncoupled remodelling so that resorption > formation.
  • Decreased bone mineral density (BMD) and deterioration of bone microarchitecture increases susceptibility to fracture.
  • Most common in post-menopausal women.
29
Q

What treatment options are there for Osteoporosis?

A

- Calcium supplementation

  • Hormone Replacement Therapy (HRT)
  • Biophosphates (potent inhibitors of boen resorption, Alendronate, Residronate, Etidronate).
  • Calcitonin
  • Selective Estrogen-Receptor Modulator (SERMs) - produces oestrogen agonist effects slectively in bone Raloxifene.
30
Q
A

B5W2 (5 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions